Heterodox
The Boston Globe has an article announcing the imminent approval of Casgevy, a CRISPR-based treatment for sickle cell disease that has already been approved in Britain.It is hard to overstate how transformative CRISPR has been for genetics research, and how promising it is for gene therapy. Sickle cell disease was always the low-hanging fruit, but there are plenty of other conditions that are being targeted for CRISPR therapy.To explain how Casgevy...
Read More »